Crystal L. Mackall, MD, to receive award for cancer gene and cell therapy research
Click Here to Manage Email Alerts
Crystal L. Mackall, MD, will receive this year’s Edward Netter Leadership Award from Alliance for Cancer Gene Therapy.
The award recognizes an individual who has made unparalleled and groundbreaking research contributions to the field of cell and gene therapy for cancer.
The award will be presented March 30 during the Alliance for Cancer Gene Therapy (ACGT) awards luncheon in New York.
Mackall is Ernest and Amelia Gallo family professor, as well as professor of pediatrics and internal medicine, at Stanford University.
She also is founding director of Stanford Center for Cancer Cell Therapy, associate director of Stanford Cancer Institute, leader of the cancer immunology program and director of Parker Institute for Cancer Immunotherapy at Stanford.
The award recognizes Mackall’s role as a leader in research and development of gene-edited cellular therapies for cancer and her lab’s efforts to translate their use into solid tumors.
Mackall’s scientific achievements include helping discover the importance of preconditioning to promote cell engraftment.
“Dr. Crystal Mackall is one of the best examples of a researcher who refused to accept the status quo of standard cancer treatment and committed to developing novel cell and gene therapies for children with difficult-to-treat tumors,” Kevin Honeycutt, CEO and president of ACGT, said in a press release. “ACGT is proud that Dr. Mackall is an ACGT research fellow, a member of ACGT’s Scientific Advisory Council and the newest recipient of the Edward Netter Leadership Award.”
Click Here to Manage Email Alerts